News

Extra Vitamin D Fails to Cut Pain Of Fibromyalgia


 

SAN DIEGO — Vitamin D supplementation did not lessen fibromyalgia symptoms in a small trial, a finding that casts doubt on the theory that vitamin D deficiency underlies some patients' pain and that screening vitamin D levels would identify patients who would benefit from supplementation, Dr. Ann Warner said in a poster presentation at the annual meeting of the American College of Rheumatology.

She performed two studies examining the vitamin D hypothesis. In one study, Dr. Warner, a rheumatologist who practices in Kansas City, Mo., took 50 fibromyalgia patients with insufficient serum levels of vitamin D (a 25-hydroxyvitamin D level less than 20 ng/mL) and randomized them to weekly doses of 50,000 IU of vitamin D or to placebo for 3 months.

The 25 patients randomized to supplementation had a higher mean pain score on a visual analog scale at baseline compared with the patients who received placebo (74 mm vs. 61 mm). The mean pain score of patients given supplemental vitamin D improved after 3 months, falling to 64 mm. However, the mean visual analog scale score of the control patients fell to a similar degree, to 54 mm, and neither group's changes were statistically significant.

Patients in the control group showed a slight, but significant improvement on the functional pain score, while the supplemented group did not.

In the second study, Dr. Warner compared 25-hydroxyvitamin D levels in 104 patients with osteoarthritis with levels in 184 fibromyalgia patients.

There was no statistically significant difference in mean levels between the groups (28.76 ng/mL for the osteoarthritis group vs. 29.16 for the fibromyalgia group) even though there was a slightly higher percentage of patients with fibromyalgia who were insufficient, 29% vs. 20%.

Recommended Reading

Bone Density Screening Guides: Experts Offer Conflicting Views
MDedge Family Medicine
Bisphosphonate Beats Alfacalcidol in Bone Trial
MDedge Family Medicine
WHO to Release Absolute Fracture Risk Index
MDedge Family Medicine
Survey Focuses on Adherence Gap in Osteoporosis Therapy
MDedge Family Medicine
Don't Stop Bisphosphonates if Early Bone Readings Show Loss
MDedge Family Medicine
Fentanyl Delivers Relief in Advanced Osteoarthritis
MDedge Family Medicine
Synvisc Injection Treatments Deemed Beneficial in Hip OA
MDedge Family Medicine
Hand Osteoarthritis Predicts Later Hip, Knee Disease Development
MDedge Family Medicine
Osteoporosis Follow-Up Found Lacking in Low-Trauma Fractures
MDedge Family Medicine
Rehabilitating an Injured Shoulder
MDedge Family Medicine